Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

In our previous study, calcitriol and its analogs PRI-2191 and PRI-2205 stimulated 4T1 mouse mammary gland cancer metastasis. Therefore, we aimed to analyze the inflammatory response in 4T1-bearing mice treated with these compounds. Gene expression analysis of the splenocytes and regional lymph nodes demonstrated prevalence of the T helper lymphocytes (Th2) response with an increased activity of regulatory T (Treg) lymphocytes in mice treated with these compounds. We also observed an increased number of mature granulocytes and B lymphocytes and a decreased number of TCD4⁺, TCD4⁺CD25⁺, and TCD8⁺, as well as natural killer (NK) CD335⁺, cells in the blood of mice treated with calcitriol and its analogs. Among the splenocytes, we observed a significant decrease in NK CD335⁺ cells and an increase in TCD8⁺ cells. Calcitriol and its analogs decreased the levels of interleukin (IL)-1β and IL-10 and increased the level of interferon gamma (IFN-γ) in the plasma. In the tumor tissue, they caused an increase in the level of IL-10. Gene expression analysis of lung tissue demonstrated an increased level of osteopontin () and transforming growth factor β (TGF-β) mRNA. The expression of was also elevated in lymph nodes. Calcitriol and its analogs caused prevalence of tumor-conducive changes in the immune system of 4T1 tumor-bearing mice, despite the induction of some tumor-disadvantageous effects.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073894PMC
http://dx.doi.org/10.3390/ijms19072116DOI Listing

Publication Analysis

Top Keywords

calcitriol analogs
20
mice treated
12
4t1 mouse
8
mouse mammary
8
mammary gland
8
gland cancer
8
treated compounds
8
gene expression
8
expression analysis
8
lymph nodes
8

Similar Publications

Evaluation of vitamin D status, vitamin D receptor expression, and innate immune mediators in COVID-19.

Front Endocrinol (Lausanne)

September 2025

Molecular Testing Laboratory, Department of Medical Laboratory Sciences, Faculty of Health Sciences, Beirut Arab University, Beirut, Lebanon.

Background And Objectives: The Coronavirus disease 2019 (COVID-19) pandemic underscored the importance of identifying host factors that influence susceptibility to infection. Vitamin D signaling, mediated via its receptor (), along with innate immune mediators such as antimicrobial peptides (e.g.

View Article and Find Full Text PDF

Chromatographic separation of dihydroxylated vitamin D and accurate quantification of 1α,25(OH)D in human serum.

J Pharm Biomed Anal

December 2025

Marketing Department, ME Business Operations, JEOL Ltd., Tokyo, Japan; Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, Tokyo, Japan. Electronic address:

The most bioactive form of dihydroxylated vitamin D (VD) is 1α,25-dihydroxyvitamin D (1α,25(OH)D), which is implicated in various physiological processes and disease development. Therefore, accurate quantification of 1α,25(OH)D is essential for clinical diagnosis, VD-related disease management, and infection control. However, 1α,25(OH)D quantification in biological samples is challenging because of its low concentration and interference from other dihydroxylated VD metabolites.

View Article and Find Full Text PDF

Multiple Sclerosis (MS) is a chronic autoimmune disorder that causes progressive neurological disability through demyelination of the central nervous system. Vitamin D deficiency has been linked to increased MS risk and activity, with adequate levels shown to modulate immune responses. However, many MS patients exhibit resistance to high-dose Vitamin D therapy, often due to impaired Vitamin D Receptor (VDR) activation, limiting its therapeutic effectiveness and increasing the risk of side effects.

View Article and Find Full Text PDF

Background: To assess the effectiveness, safety, and quality of life in patients who received topical calcipotriene/betamethasone dipropionate (C/BD) foam added to oral deucravacitinib for treating moderate to severe, chronic plaque psoriasis.

Methods: In this prospective, open-label, single-center study, adults (≥18 years of age) with psoriasis (physician global assessment [PGA] ≥3, body surface area [BSA] ≥10%, and psoriasis area severity index [PASI] ≥12) took deucravacitinib (6 mg daily) for 8 weeks. At week 8, patients who achieved PASI 75 continued on deucravacitinib alone up to week 24; PASI 25-74 used daily, C/BD for 4 weeks; and <PASI 25 were discontinued.

View Article and Find Full Text PDF

Real-world data from a national survey on management of CKD-associated osteoporosis among Italian nephrologists.

Arch Osteoporos

July 2025

Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.

Unlabelled: Chronic kidney disease (CKD)-associated osteoporosis increases fracture risk, yet clinical guidance remains unclear. A survey of 89 Italian nephrologists revealed heterogeneous biomarker availability and varied treatment approaches. Denosumab was the preferred antiresorptive agent, while anabolic drugs were rarely used.

View Article and Find Full Text PDF